Sign In
Buy EFX
Equifax Earnings Calls
| Release date | Apr 21, 2026 |
| EPS estimate | $1.69 |
| EPS actual | $1.86 |
| EPS Surprise | 10.06% |
| Revenue estimate | 1.617B |
| Revenue actual | 1.649B |
| Revenue Surprise | 1.97% |
| Release date | Feb 04, 2026 |
| EPS estimate | $2.06 |
| EPS actual | $2.09 |
| EPS Surprise | 1.46% |
| Revenue estimate | 1.528B |
| Revenue actual | 1.551B |
| Revenue Surprise | 1.48% |
| Release date | Oct 21, 2025 |
| EPS estimate | $1.94 |
| EPS actual | $2.04 |
| EPS Surprise | 5.15% |
| Revenue estimate | 1.522B |
| Revenue actual | 1.545B |
| Revenue Surprise | 1.49% |
| Release date | Jul 22, 2025 |
| EPS estimate | $1.93 |
| EPS actual | $2.00 |
| EPS Surprise | 3.63% |
| Revenue estimate | 1.513B |
| Revenue actual | 1.537B |
| Revenue Surprise | 1.55% |
Last 4 Quarters for Equifax
Below you can see how EFX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 22, 2025 |
| Price on release | $238.41 |
| EPS estimate | $1.93 |
| EPS actual | $2.00 |
| EPS surprise | 3.63% |
| Date | Price |
|---|---|
| Jul 16, 2025 | $259.33 |
| Jul 17, 2025 | $261.42 |
| Jul 18, 2025 | $263.09 |
| Jul 21, 2025 | $259.64 |
| Jul 22, 2025 | $238.41 |
| Jul 23, 2025 | $245.86 |
| Jul 24, 2025 | $245.98 |
| Jul 25, 2025 | $246.26 |
| Jul 28, 2025 | $240.95 |
| 4 days before | -8.07% |
| 4 days after | 1.07% |
| On release day | 3.12% |
| Change in period | -7.09% |
| Release date | Oct 21, 2025 |
| Price on release | $229.93 |
| EPS estimate | $1.94 |
| EPS actual | $2.04 |
| EPS surprise | 5.15% |
| Date | Price |
|---|---|
| Oct 15, 2025 | $229.64 |
| Oct 16, 2025 | $227.20 |
| Oct 17, 2025 | $226.91 |
| Oct 20, 2025 | $231.12 |
| Oct 21, 2025 | $229.93 |
| Oct 22, 2025 | $230.64 |
| Oct 23, 2025 | $231.31 |
| Oct 24, 2025 | $233.80 |
| Oct 27, 2025 | $229.02 |
| 4 days before | 0.126% |
| 4 days after | -0.396% |
| On release day | 0.309% |
| Change in period | -0.270% |
| Release date | Feb 04, 2026 |
| Price on release | $181.04 |
| EPS estimate | $2.06 |
| EPS actual | $2.09 |
| EPS surprise | 1.46% |
| Date | Price |
|---|---|
| Jan 29, 2026 | $204.00 |
| Jan 30, 2026 | $201.40 |
| Feb 02, 2026 | $199.17 |
| Feb 03, 2026 | $175.05 |
| Feb 04, 2026 | $181.04 |
| Feb 05, 2026 | $191.01 |
| Feb 06, 2026 | $195.62 |
| Feb 09, 2026 | $199.59 |
| Feb 10, 2026 | $202.71 |
| 4 days before | -11.25% |
| 4 days after | 11.97% |
| On release day | 5.51% |
| Change in period | -0.632% |
| Release date | Apr 21, 2026 |
| Price on release | $192.42 |
| EPS estimate | $1.69 |
| EPS actual | $1.86 |
| EPS surprise | 10.06% |
| Date | Price |
|---|---|
| Apr 15, 2026 | $186.85 |
| Apr 16, 2026 | $190.38 |
| Apr 17, 2026 | $196.22 |
| Apr 20, 2026 | $198.45 |
| Apr 21, 2026 | $192.42 |
| Apr 22, 2026 | $178.66 |
| Apr 23, 2026 | $174.93 |
| Apr 24, 2026 | $172.47 |
| Apr 27, 2026 | $170.57 |
| 4 days before | 2.98% |
| 4 days after | -11.36% |
| On release day | -7.15% |
| Change in period | -8.71% |
Equifax Earnings Call Transcript Summary of Q1 2026
Equifax reported a strong Q1 2026 with reported revenue of $1.649 billion (up 14%) and organic constant-currency growth of 13%. Mortgage was the standout driver — U.S. mortgage revenue grew sharply (Mark: EWS mortgage +14%; USIS mortgage +60% total, +24% ex-FICO) driven by stronger activity early in the quarter and adoption of Equifax’s TWN Indicator and other new products. Excluding FICO score pass-throughs, the company grew about 10% (top end of its long-term framework) and delivered EBITDA of $477 million (+13%) with EBITDA margin expansion (ex-FICO) of ~80 bps in Q1. Equifax emphasized new-product momentum powered by its cloud-native EFX.AI platform and proprietary data (record Vitality Index 17%, ~400 AI patents pending/granted), driving NPI velocity and AI-driven cost productivity. Management is maintaining full-year 2026 guidance provided in February despite the Q1 outperformance, citing uncertainty from the Iran conflict and recent rate/market volatility that reduced mortgage activity in late March/April. Key financial guidance: FY2026 revenue midpoint raised slightly for FX to $6.745B, adjusted EPS midpoint to $8.54, diversified markets growth expected high-single-digits, U.S. mortgage revenue >20% (market originations down low-single-digits), EBITDA margin expansion ex-FICO targeted at +75 bps for the year, and free cash flow >$1B with cash conversion >100%. The company repurchased $260M of stock in Q1, increased the quarterly dividend 12%, and expects roughly $1.5B of 2026 capital capacity for bolt-on M&A and returns to shareholders. On credit scoring, Equifax is actively promoting VantageScore (recently priced at $1 for mortgage to accelerate adoption) but conservatively assumes no industry-wide conversion in 2026; if conversion occurs it would reduce score pass-through revenue but increase Equifax margins (estimated $35M margin upside at current mortgage run rates). Management signaled continued focus on TWN indicator rollouts (now expanded into auto, card, and personal loans), government opportunities from OB3/Medicaid/SNAP validations (pipeline 2x year-over-year), and material multi-year AI-driven productivity upside as cloud and EFX.AI adoption accelerates.
